Trial Profile
JIKEI mitigulinide vs sitagliptin study on glycemic variance using continuous glucose monitoring.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Mitiglinide (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms J-MISSION
- 05 Oct 2012 Status changed from recruiting to completed as assumed from the abstract presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 28 Apr 2011 New trial record